Certainly, in a case of diabesity, the use of a short-acting glucagon infusion only will aggravate hyperglycaemia; thus, a proper additional insulin therapy would be crucial to maintain euglycaemia and accelerate energy expenditure in patients with insulin-deficient diabetes. This evidence concerns the gene GCG and diabetes mellitus.